Pneumonia News and Research

Latest Pneumonia News and Research

Study recommends chest ultrasound for evaluating pediatric patients with complicated pneumonia

Chest ultrasound can serve as a viable alternative to chest CT in the evaluation of pediatric patients with complicated pneumonia and parapneumonic effusion (a build-up of fluid between the lung and chest wall), according to a study published in the December issue of the American Journal of Roentgenology.

20 Nov 2009

Leading driver of antibiotic selection in nosocomial pneumonia in Europe found

Arlington Medical Resources (AMR) and Decision Resources find that the leading driver of antibiotic selection in nosocomial pneumonia in Europe is broad-spectrum activity against gram-positive and gram-negative pathogens.

20 Nov 2009

FDA Advisory Committee votes in support of Pfizer's Prevnar 13

Pfizer Inc announced today that the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee voted 10 to 1 that the data presented support the safety and effectiveness of its 13-valent pneumococcal conjugate candidate vaccine, Prevnar 13™ (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]), for the prevention of invasive pneumococcal disease in infants and young children.

19 Nov 2009

Millennium commences Phase I clinical trial for its second-generation proteasome inhibitor

Millennium: The Takeda Oncology Company today announced it has further expanded its protein homeostasis program with the initiation of a Phase I clinical trial for an oral formulation of MLN9708, the Company’s second-generation proteasome inhibitor. An intravenous formulation of MLN9708 entered clinical trials in March.

18 Nov 2009

Pentavalent price drops: the GAVI effect

Following the increasing impact of the GAVI Alliance on the vaccine market, the price of one of the major combination vaccines, the pentavalent, is falling considerably, enabling GAVI’s partners to vaccinate millions of more children in the developing world.

18 Nov 2009

Regulatory agencies offer marketing approval for new products to treat neglected diseases

New products to treat neglected diseases have received marketing approval from regulatory agencies at a steadily increasing rate in recent years as R&D funding for those diseases has increased, according to a recently completed study by the Tufts Center for the Study of Drug Development.

18 Nov 2009

Report calls for refocusing health spending in developing countries to save children's lives

"More than 24,000 infants die daily from preventable diseases in developing countries," and child deaths have fallen in countries where governments "have shown a high level of political leadership on child health," World Vision International said in a new report (.pdf) released on Monday as part of a five-year campaign to reduce child deaths worldwide, the Associated Press/San Francisco Chronicle reports.

17 Nov 2009

Hospitals should expand quality control guidelines to improve surgical complications in older patients

The elderly are more vulnerable to problems after a major surgical procedure than younger patients, but a team of investigators using data from the American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP) suggest that one way to improve surgical results in this age group is to have hospitals expand their quality control guidelines to include more types of surgery-related complications.

17 Nov 2009

Opinions: Health system funding; malnutrition assistance; social dimension of HIV

"For too long, global health funding has gone to diseases like AIDS with the most vocal lobby groups and not to the diseases with the greatest need," Philip Stevens, a senior fellow at International Policy Network, writes in a Business Daily opinion piece.

16 Nov 2009

Alkermes' phase 3 trial of naltrexone XR-NTX meets primary endpoint

Alkermes, Inc. today announced positive preliminary results from a phase 3 clinical trial of naltrexone for extended-release injectable suspension (XR-NTX) for the treatment of opioid dependence. The six-month phase 3 study met its primary efficacy endpoint and data showed that patients treated once-monthly with XR-NTX demonstrated statistically significant higher rates of clean (opioid-free) urine screens, compared to patients treated with placebo, as measured by the cumulative distribution of clean urine screens (p<0.0002).

16 Nov 2009

Low-cost, simple interventions could save 2.5 million child lives a year: World Vision

Almost a third of the children under age five who die each year could be saved if governments rebalance health spending to ensure low-cost, simple interventions such as safe water and hygiene, bed nets and basic maternal and newborn care, leading aid agency World Vision said today. Currently, 8.8 million children a year die before age five, most of preventable causes.

16 Nov 2009

UT physicians treat Iraqi girl with myasthenia gravis

Plagued by a growing weakness that left her unable to walk, talk and even take a normal breath, 11-year-old Iraqi Aram Ali was a shell of the bright little girl she used to be.

16 Nov 2009

WHO revises clinical H1N1 guidelines, sends antivirals to some hard-hit nations

On Thursday, the WHO issued revised guidance for the clinical management of H1N1 (swine) flu, the Associated Press reports. According to the AP, the WHO "says doctors shouldn't wait for lab confirmation before giving anti-viral drugs to pregnant women and other at-risk groups with suspected swine flu" (11/12).

16 Nov 2009

Study of GBHN Order Set project reveals improvements in the length of stay and ordering of best practices

A study of the Grey Bruce Health Network (GBHN) Order Set project has revealed impressive improvements in the length of stay and ordering of best practices.

13 Nov 2009

CDC expected to revise estimated number of U.S. H1N1 deaths

Ahead of the anticipated CDC release of revised U.S. H1N1 (swine flu) death toll estimates, Reuters examines how the agency and WHO measure the impact of the virus, after both organizations "stopped trying to count actual cases months ago, once it became clear that H1N1 was a pandemic that would infect millions."

12 Nov 2009

Almost 200m undernourished children worldwide, report says

In developing countries, almost 200 million children under the age of 5 "suffer from stunted growth and health problems due to poor nutrition in their early years," according to a UNICEF report released on Wednesday, Reuters reports.

12 Nov 2009

CDC expected to revise H1N1 mortality figures

The New York Times: "About 4,000 Americans - rather than about 1,200 - have died of swine flu since the disease emerged in April, according to new figures being calculated by [CDC] epidemiologists" - an estimate that combines the number of "deaths from laboratory-confirmed cases of the flu and deaths that appear to be brought on by flu, even though the patient may have ultimately died of bacterial pneumonia, other infections or organ failure."

12 Nov 2009

Bayfront Medical Center to implement CareFocus clinical surveillance solution from Thomson Reuters

Bayfront Medical Center has selected Clinical Xpert CareFocus from Thomson Reuters as its clinical surveillance solution for improving Core Measures outcomes and patient safety indicator (PSI) scores while also supporting infection control and pharmacy intervention initiatives.

10 Nov 2009

Prolonged ED wait time is associated with poor clinical outcomes

One in four emergency department patients in 2006 waited longer to be evaluated by a clinician than recommended at triage, an increase from one in five in 1997, according to a report in the November 9 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

10 Nov 2009

Affordable health care can save millions of women, newborns, and children in sub-Saharan Africa

The lives of almost 4 million women, newborns, and children in sub-Saharan Africa could be saved every year if well-established, affordable health care interventions reached 90 percent of families, according to a joint report by the national science academies of seven African countries.

10 Nov 2009

Pneumonia News and Research

Latest Pneumonia News and Research

Study recommends chest ultrasound for evaluating pediatric patients with complicated pneumonia

Leading driver of antibiotic selection in nosocomial pneumonia in Europe found

FDA Advisory Committee votes in support of Pfizer's Prevnar 13

Millennium commences Phase I clinical trial for its second-generation proteasome inhibitor

Pentavalent price drops: the GAVI effect

Regulatory agencies offer marketing approval for new products to treat neglected diseases

Report calls for refocusing health spending in developing countries to save children's lives

Hospitals should expand quality control guidelines to improve surgical complications in older patients

Opinions: Health system funding; malnutrition assistance; social dimension of HIV

Alkermes' phase 3 trial of naltrexone XR-NTX meets primary endpoint

Low-cost, simple interventions could save 2.5 million child lives a year: World Vision

UT physicians treat Iraqi girl with myasthenia gravis

WHO revises clinical H1N1 guidelines, sends antivirals to some hard-hit nations

Study of GBHN Order Set project reveals improvements in the length of stay and ordering of best practices

CDC expected to revise estimated number of U.S. H1N1 deaths

Almost 200m undernourished children worldwide, report says

CDC expected to revise H1N1 mortality figures

Bayfront Medical Center to implement CareFocus clinical surveillance solution from Thomson Reuters

Prolonged ED wait time is associated with poor clinical outcomes

Affordable health care can save millions of women, newborns, and children in sub-Saharan Africa

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Pneumonia News and Research

Latest Pneumonia News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in